Iattoni, Elena
Iattoni, Elena
M09Quantification of circulating cell-free DNA by fluorimetry (Qubit) and spectrophotometry (NanoDrop) in patients with malignant melanoma and prostate cancer
2016 Ponti, G.; Maccaferri, M.; Depenni, R.; Mandrioli, M.; Pellacani, G.; Manfredini, M.; Ozben, T.; Ruini, C.; Iattoni, E.; Cerioli, D.; Cascinu, S.; Tomasi, A.
Molecular profile in primary and metastatic breast cancer treated with Exemestane and Everolimus.
2016 Filieri, Maria Elisabetta; Bettelli, Stefania Raffaella; Maiorana, Antonio; Caprera, Cecilia; Manfredini, Samantha; Caggia, Federica; Iattoni, Elena; Cascinu, Stefano; Omarini, Claudia; Piacentini, Federico
Pre and post anti Her-2 therapy era: a mono-institutional analysis of the outcome in patients with residual disease after neoadjuvant therapy for Her-2 positive locally advanced breast cancer.
2016 Iattoni, E.; Omarini, C.; Tamma, A. V.; Noventa, S.; Piacentini, F.; Moscetti, L.; Cascinu, S.
Predictive role of haemoglobin on disease response to neoadjuvant chemotherapy in breast cancer.
2016 Omarini, Claudia; Iattoni, Elena; Filieri, Maria Elisabetta; Toss, Angela; Grizzi, Giulia; DEL GIOVANE, Cinzia; Valentina Tamma, Antonella; Cascinu, Stefano; Piacentini, Federico
Quantification of circulating cell-free DNA by fluorimetry (Qubit) and spectrophotometry (NanoDrop) in patients with malignant melanoma and prostate cancer
2016 Ponti, Giovanni; Maccaferri, M; Depenni, Roberta; Mandrioli, Mauro; Pellacani, Giovanni; Manfredini, M; Ozben, T; Ruini, C; Iattoni, Elena; Cerioli, Davide; Cascinu, Stefano; Tomasi, Aldo
Safety and efficacy of T-DM1 in HER2 positive metastatic breast cancer patients: a real word experience.
2016 Omarini, Claudia; Medici, Gregorio; Guaitoli, Giorgia; Iattoni, Elena; Moscetti, Luca; Balduzzi, Sara; Cascinu, Stefano; Piacentini, Federico
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| M09Quantification of circulating cell-free DNA by fluorimetry (Qubit) and spectrophotometry (NanoDrop) in patients with malignant melanoma and prostate cancer | 1-gen-2016 | Ponti, G.; Maccaferri, M.; Depenni, R.; Mandrioli, M.; Pellacani, G.; Manfredini, M.; Ozben, T.; Ruini, C.; Iattoni, E.; Cerioli, D.; Cascinu, S.; Tomasi, A. | |
| Molecular profile in primary and metastatic breast cancer treated with Exemestane and Everolimus. | 1-gen-2016 | Filieri, Maria Elisabetta; Bettelli, Stefania Raffaella; Maiorana, Antonio; Caprera, Cecilia; Manfredini, Samantha; Caggia, Federica; Iattoni, Elena; Cascinu, Stefano; Omarini, Claudia; Piacentini, Federico | |
| Pre and post anti Her-2 therapy era: a mono-institutional analysis of the outcome in patients with residual disease after neoadjuvant therapy for Her-2 positive locally advanced breast cancer. | 1-gen-2016 | Iattoni, E.; Omarini, C.; Tamma, A. V.; Noventa, S.; Piacentini, F.; Moscetti, L.; Cascinu, S. | |
| Predictive role of haemoglobin on disease response to neoadjuvant chemotherapy in breast cancer. | 1-gen-2016 | Omarini, Claudia; Iattoni, Elena; Filieri, Maria Elisabetta; Toss, Angela; Grizzi, Giulia; DEL GIOVANE, Cinzia; Valentina Tamma, Antonella; Cascinu, Stefano; Piacentini, Federico | |
| Quantification of circulating cell-free DNA by fluorimetry (Qubit) and spectrophotometry (NanoDrop) in patients with malignant melanoma and prostate cancer | 1-gen-2016 | Ponti, Giovanni; Maccaferri, M; Depenni, Roberta; Mandrioli, Mauro; Pellacani, Giovanni; Manfredini, M; Ozben, T; Ruini, C; Iattoni, Elena; Cerioli, Davide; Cascinu, Stefano; Tomasi, Aldo | |
| Safety and efficacy of T-DM1 in HER2 positive metastatic breast cancer patients: a real word experience. | 1-gen-2016 | Omarini, Claudia; Medici, Gregorio; Guaitoli, Giorgia; Iattoni, Elena; Moscetti, Luca; Balduzzi, Sara; Cascinu, Stefano; Piacentini, Federico |